Director · BridgeBio Pharma, Inc. (BBIO)

Charles Homcy, M.D director compensation at BridgeBio (FY2025): $1.1M

Fiscal year 2025 director compensation for Charles Homcy, M.D at BridgeBio Pharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Charles Homcy, M.D’s full pay file as a PDF — free

More than this page: up to 10 years of Charles’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Charles Homcy, M.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BridgeBio Pharma Director Compensation Table · all 5 fiscal years held
In US dollars, as BridgeBio Pharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$50,000$274,959$274,988$524,167$1,124,114
FY2024$50,000$0$549,998$517,646$1,117,644
FY2023$50,000$0$549,995$513,200$1,113,195
FY2022$50,000$234,608$549,996$158,000$992,604
FY2021$50,000$109,375$2,199,979$511,600$2,870,954

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BridgeBio Pharma, Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016723, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BridgeBio Pharma, Inc. filed document, accession 0001140361-26-016723. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the BridgeBio Pharma Board Governance Report

$1,124,114 Charles Homcy, M.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

The rest of the BridgeBio Pharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Ali J. SatvatIndependent Director$599,947
Andrea J. EllisIndependent Director$599,947
Andrew W. LoIndependent Director$649,947
Andrew W. Lo, Ph.DIndependent Director$649,947
Douglas A. DachilleIndependent Director$599,947
Eric Aguiar, M.DIndependent Director$599,947
Frank P. McCormick, Ph.D., F.R.S., D.ScDirector$1,099,947
Fred HassanLead Independent Director$599,947
Hannah A. Valantine, M.DIndependent Director$599,947
James C. MomtazeeIndependent Director$599,947
Jennifer E. CookIndependent Director$599,947
Neil Kumar, Ph.DDirector—
Randal W. Scott, Ph.DIndependent Director$599,947
Ronald J. DanielsIndependent Director$599,947

The full BridgeBio Pharma compensation record

free company brief

This page is one director within BridgeBio Pharma's record. The company brief lists every named executive and director, each linking to their own page.

Order BBIO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report